GVBLBiotechnology
Genomic Valley Biotech Ltd — Cash Flow Statement
₹28.00
+3.74%
Genomic Valley Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 0.02 Cr | -0.02 Cr | -0.78 Cr | -2.13 Cr | — |
| Issuance Of Debt | 0.00 | 0.00 | — | — | 0.07 Cr |
| Capital Expenditure | -91763.00 | — | — | — | -1.58 Cr |
| End Cash Position | 0.05 Cr | 60734.00 | 0.04 Cr | 26791.00 | — |
| Other Cash Adjustment Outside Changein Cash | 1.00 | 1.00 | — | — | — |
| Beginning Cash Position | 60734.00 | 0.04 Cr | 26791.00 | 0.01 Cr | — |
| Changes In Cash | 0.04 Cr | -0.04 Cr | 0.04 Cr | -87741.00 | — |
| Financing Cash Flow | 0.00 | 0.00 | -0.70 Cr | -1.55 Cr | — |
| Net Issuance Payments Of Debt | 0.00 | 0.00 | -0.70 Cr | -1.55 Cr | — |
| Net Long Term Debt Issuance | 0.00 | 0.00 | -0.70 Cr | -1.55 Cr | — |
| Long Term Debt Issuance | 0.00 | 0.00 | — | — | 0.07 Cr |
| Investing Cash Flow | 0.01 Cr | -0.02 Cr | 1.52 Cr | 3.67 Cr | — |
| Net Other Investing Changes | 44660.00 | 15003.00 | — | -1.60 Cr | — |
| Interest Received Cfi | 0.00 | 0.00 | 0.04 Cr | -0.08 Cr | — |
| Net Investment Purchase And Sale | 0.02 Cr | -0.02 Cr | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -91763.00 | 0.00 | 1.48 Cr | 5.35 Cr | — |
| Operating Cash Flow | 0.03 Cr | -0.02 Cr | -0.78 Cr | -2.13 Cr | — |
| Taxes Refund Paid | -0.09 Cr | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | -0.33 Cr | -0.03 Cr | -1.66 Cr | -1.45 Cr | — |
| Change In Other Current Liabilities | -0.33 Cr | -0.10 Cr | 0.68 Cr | -0.66 Cr | — |
| Change In Other Current Assets | 0.30 Cr | -0.06 Cr | 0.82 Cr | -1.05 Cr | — |
| Change In Prepaid Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Inventory | -0.28 Cr | 0.00 | 0.00 | 0.00 | — |
| Change In Receivables | -55239.00 | 0.12 Cr | -3.15 Cr | 0.26 Cr | — |
| Other Non Cash Items | -44660.00 | -15003.00 | -0.04 Cr | 0.08 Cr | — |
| Depreciation And Amortization | 25414.00 | 10925.00 | 79243.00 | 0.08 Cr | — |
| Depreciation | 25414.00 | 10925.00 | 79243.00 | 0.08 Cr | — |
| Net Income From Continuing Operations | 0.44 Cr | 0.02 Cr | 0.91 Cr | -0.42 Cr | — |
| Repayment Of Debt | — | 0.00 | -0.70 Cr | -1.55 Cr | — |
| Long Term Debt Payments | — | 0.00 | -0.70 Cr | -1.55 Cr | — |
| Gain Loss On Investment Securities | — | — | — | -0.42 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Genomic Valley Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.